Evidence map›Paper›PMID 39061712›Full record

ArticleDiagnostics (Basel, Switzerland)2024

Validation of Contrast-Enhanced Mammography as Breast Imaging Modality Compared to Standard Mammography and Digital Breast Tomosynthesis.

Nina Bartolović, Ana Car Peterko, Manuela Avirović, Doris Šegota Ritoša, Emina Grgurević Dujmić, Petra Valković Zujić

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nina BartolovićDepartment of Diagnostic and Interventional Radiology, Clinical Hospital Centre Rijeka, Kresimirova 42, 51000 Rijeka, Croatia.ORCID 0000-0003-1402-8904
Ana Car PeterkoDepartment of General Surgery and Surgical Oncology, Clinical Hospital Centre Rijeka, Kresimirova 42, 51000 Rijeka, Croatia.ORCID 0000-0003-3148-0126
Manuela AvirovićDepartment of Pathology, Faculty of Medicine, University of Rijeka, Brace Branchetta 20, 51000 Rijeka, Croatia.
Doris Šegota RitošaMedical Physics and Radiation Protection Department, Clinical Hospital Centre Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0002-2746-9584
Emina Grgurević DujmićCommunity Health Centre Primorsko-Goranska County, Kresimirova 52A, 51000 Rijeka, Croatia.
Petra Valković ZujićDepartment of Diagnostic and Interventional Radiology, Clinical Hospital Centre Rijeka, Kresimirova 42, 51000 Rijeka, Croatia.

Funding

University of Rijeka UNIRI INOVA 3-23-1
6 · The paper itself

Abstract

Contrast-enhanced mammography (CEM) is a relatively new imaging technique that allows morphologic, anatomic and functional imaging of the breast. The aim of our study was to validate contrast-enhanced mammography (CEM) compared to mammography (MMG) and digital breast tomosynthesis (DBT) in daily clinical practice. This retrospective study included 316 consecutive patients who underwent MMG, DBT and CEM at the Centre for Prevention and Diagnosis of Chronic Diseases of Primorsko-goranska County. Two breast radiologists independently analyzed the image data, without available anamnestic information and without the possibility of comparison with previous images, to determine the presence of suspicious lesions and their morphological features according to the established criteria of the Breast Imaging Reporting and Data System (BI-RADS) lexicon. The diagnostic value of MMG, DBT and CEM was assessed by ROC analysis. The interobserver agreement was excellent. CEM showed higher diagnostic accuracy in terms of sensitivity and specificity compared to MMG and DBT, the reporting time for CEM was significantly shorter, and CEM findings resulted in a significantly lower proportion of equivocal findings (BI-RADS 0), suggesting fewer additional procedures. In conclusion, CEM achieves high diagnostic accuracy while maintaining simplicity, reproducibility and applicability in complex clinical settings.

Indexed as

breast cancercontrast mediadigital breast tomosynthesismammography

Identifiers

PMID39061712
PMCPMC11275490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.